https://www.ncbi.nlm.nih.gov/pubmed/30703247 Autoimmune hepatitis
Acta Paediatr. 2019 Jan 31. doi: 10.1111/apa.14730. [Epub ahead of print]
Adequacy of scoring systems in diagnosing paediatric autoimmune hepatitis: retrospective study using a control group children with Hepatitis B infection.
Niță AF1,2, Păcurar D1,2.
Abstract
AIM:
To evaluate how correct is made the diagnosis of autoimmune hepatitis (AIH) in children, comparing the adults scoring systems - the 1999 revised scoring system by International Autoimmune Hepatitis Group and the 2007 Simplified Scoring System. The inaccuracies in diagnosis have been analysed.
METHODS:
|
https://www.ncbi.nlm.nih.gov/pubmed/30578461 NAFLD
Adv Exp Med Biol. 2018 Dec 22. doi: 10.1007/5584_2018_318. [Epub ahead of print]
Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).
Nobili V1,2, Mosca A3, Alterio T3, Cardile S3, Putignani L4,5.
Abstract
|
https://www.ncbi.nlm.nih.gov/pubmed/30551665 NAFLD
Children (Basel). 2018 Dec 13;5(12). pii: E169. doi: 10.3390/children5120169.
Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease.
Alfani R1,2, Vassallo E3,4, De Anseris AG5, Nazzaro L6, D'Acunzo I7,8, Porfito C9,10, Mandato C11, Vajro P12,13,14,15.
Abstract
|
https://www.ncbi.nlm.nih.gov/pubmed/30588836 NAFLD
Antioxid Redox Signal. 2018 Dec 27. doi: 10.1089/ars.2018.7704. [Epub ahead of print]
The antioxidant effects of Hydroxytyrosol and Vitamin E on pediatric NAFLD, in a clinical trial: a new treatment?
Nobili V1, Alisi A2, Mosca A3, Crudele A4, Zaffina S5, Denaro M6, Smeriglio A7, Trombetta D8.
Abstract
TRIAL DESIGN:
|
https://www.ncbi.nlm.nih.gov/pubmed/30574003 Neonatal cholestasis
Clin Med Insights Pediatr. 2018 Dec 6;12:1179556518805412. doi: 10.1177/1179556518805412. eCollection 2018.
Neonatal Cholestasis: A Pandora's Box.
Pandita A1, Gupta V2, Gupta G2.
Abstract
|
https://www.ncbi.nlm.nih.gov/pubmed/30597734 Biliary atresia
Pediatr Transplant. 2018 Dec 30:e13339. doi: 10.1111/petr.13339. [Epub ahead of print]
Acute-on-chronic liver failure in children with biliary atresia awaiting liver transplantation.
D'Souza R1, Grammatikopoulos T1, Pradhan A2, Sutton H1, Douiri A3, Davenport M1, Verma A1,4, Dhawan A1.
Abstract
OBJECTIVES:
|
https://www.ncbi.nlm.nih.gov/pubmed/30577227 Liver transplant
Transplant Proc. 2018 Dec;50(10):3496-3500. doi: 10.1016/j.transproceed.2018.05.025. Epub 2018 May 30.
Mild to Moderate Intrapulmonary Shunting in Pediatric Liver Transplantation: Is Screening Necessary?
Mali VP1, Fukuda A2, Shigeta T2, Uchida H2, Kanazawa H2, Hirata Y2, Rahayatri T3, Chiaki B4, Sasaki K2, Kitamura M5, Sakamoto S2, Kasahara M2.
Abstract
BACKGROUND:
Despite reported associations between intrapulmonary vascular shunting (IPVS) and morbidity and mortality in pediatric liver transplantation (LT), there are no guidelines for screening.
OBJECTIVE:
To investigate IPVS before and after pediatric LT.
METHODS:
|
https://www.ncbi.nlm.nih.gov/pubmed/30601174 NAFLD
Curr Opin Clin Nutr Metab Care. 2018 Dec 28. doi: 10.1097/MCO.0000000000000539. [Epub ahead of print]
Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand?
Spooner MH1, Jump DB.
Abstract
PURPOSE OF REVIEW:
|
https://www.ncbi.nlm.nih.gov/pubmed/30577244 Liver transplant
Transplant Proc. 2018 Dec;50(10):3601-3605. doi: 10.1016/j.transproceed.2018.04.035. Epub 2018 Apr 18.
Outcomes of Pediatric Liver Transplantation: Deceased Donor Liver Transplantation vs Living Donor Liver Transplantation.
Zhang R1, Zhu ZJ2, Sun LY3, Wei L4, Qu W4, Zeng ZG4, Liu Y4.
Author information
Abstract
BACKGROUND:
The use of pediatric donor liver for pediatric liver transplantation (LT) remains controversial and few studies have focused on pediatric deceased donors. To address this issue, we decided to perform a retrospective research, trying to compare the clinical effects between deceased donor LTs (DDLTs) and living donor LTs (LDLTs).
METHODS:
|
https://www.ncbi.nlm.nih.gov/pubmed/30515702 Drug induced hepatitis
Indian J Pediatr. 2018 Dec 4. doi: 10.1007/s12098-018-2812-z. [Epub ahead of print]
Revised Antituberculosis Drug Doses and Hepatotoxicity in HIV Negative Children.
Indumathi CK1, Sethuraman A2, Jain S2, Krishnamurthy S2
Abstract
OBJECTIVES:
To compare the incidence of anti tuberculosis drug-induced hepatotoxicity (ATDH) with those on old vs. revised WHO doses in human immunodeficiency virus (HIV) negative children. The secondary objective was to determine the overall incidence of hepatitis in children on Anti tubercular treatment (ATT) and isoniazid prophylactic therapy (IPT).
METHODS:
|